MTSL Issue 869

 Comments Off on MTSL Issue 869
Jan 212018
 
MTSL Issue 869

MTSL Issue 869 (dated 01/18/18) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ALKS #ESPR #INCY #MDGL #MDCO #NKTR #PCRX #SGMO #ZIOP

Jan 092018
 
What Last Year's Top Stock Pickers Are Buying In 2018

At the start of each year for over three decades, the editorial team at MoneyShow.com surveys the nation’s leading newsletter advisors for their favorite stocks for the year ahead. We asked last year’s six top performers for an update on their 2017 picks and for their new favorite buys for 2018.

Dec 292017
 
MoneyShow's Top Stock Pickers of 2017

Top Stock Pickers of 2017: Biotechnology expert John McCamant deserves special recognition; his top pick from last year rose an astounding 519%. We’ve asked John, and all these other outstanding advisors, to share their updated opinions on these top performing stocks from last year’s Top Picks 2017 report.

MTSL Issue 867

 Comments Off on MTSL Issue 867
Dec 242017
 
MTSL Issue 867

MTSL Issue 867 (dated 12/21/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #BMRN #INCY #IONS #MDGL #NKTR #NVAX #SGMO #ZIOP

MTSL Issue 866

 Comments Off on MTSL Issue 866
Dec 102017
 
MTSL Issue 866

MTSL Issue 866 (dated 12/07/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ALKS #MDGL #MDCO #NVAX

MTSL Issue 863

 Comments Off on MTSL Issue 863
Oct 292017
 
MTSL Issue 863

MTSL Issue 863 (dated 10/26/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ALKS #ESPR #INCY #XON #MDGL #MDCO

MTSL Issue 861

 Comments Off on MTSL Issue 861
Oct 012017
 
MTSL Issue 861

MTSL Issue 861 (dated 9/28/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ALKS #MDGL #NKTR

MTSL Issue 858

 Comments Off on MTSL Issue 858
Aug 202017
 
MTSL Issue 858

MTSL Issue 858 (dated 8/17/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ACAD #ANTH #BMRN #ESPR #FPRX #INCY #IONS #MDCO #MDGL #NKTR #PCRX #SGMO #XON #ZIOP

MTSL Issue 850

 Comments Off on MTSL Issue 850
Apr 232017
 
MTSL Issue 850

MTSL Issue 850 (dated 4/20/17) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #IONS #INCY #MDGL #NKTR #ZIOP

‘Access to Management’ Conference Call with Madrigal (MDGL)- 4-4-17

 Comments Off on ‘Access to Management’ Conference Call with Madrigal (MDGL)- 4-4-17
Apr 052017
 
'Access to Management' Conference Call with Madrigal (MDGL)- 4-4-17

BIOINVEST Access to Management Webinar – Madrigal (MDGL)– We are pleased to announce another BioInvest “Access to Management Call.” Below is the link to the recorded webinar presentation with the Senior Management Team of Madrigal.

Top Picks 2017: Madrigal

 Comments Off on Top Picks 2017: Madrigal
Jan 242017
 
Top Picks 2017: Madrigal

Non-alcoholic steatohepatitis, or NASH, is one of the largest disease opportunities we have ever seen, explains John McCamant, editor of The Medical technology Stock Letter.

MTSL Issue 841

 Comments Off on MTSL Issue 841
Dec 042016
 
MTSL Issue 841

MTSL Issue 841 (dated 12/1/16) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ACAD #MDGL #SGMO

Madrigal Pharmaceuticals (MDGL) 10-25-16

 Comments Off on Madrigal Pharmaceuticals (MDGL) 10-25-16
Oct 252016
 
Madrigal Pharmaceuticals (MDGL) 10-25-16

BIOINVEST Update – (New Recommendation) Madrigal Pharmaceuticals (MDGL) – Paul Friedman Is Back

NASH is a hot topic in Biotech since September when Allergan bought Tobira Therapeutics (TBRA) for a stunning $1.7 billion for a Phase II asset. The Tobira deal was done at a tremendous 500% premium and topped the $1.2 billion Gilead paid for a NASH drug candidate being developed by Nimbus Therapeutics.

MTSL Issue 838

 Comments Off on MTSL Issue 838
Oct 232016
 
MTSL Issue 838

MTSL Issue 838 (dated 10/20/16) of Medical Technology #Stock Letter from BioInvest includes #Biotech Sector Analysis & updates: #ALKS #MDGL #MDCO